BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36734894)

  • 1. LSINCT5: A Novel lncRNA in Cancers.
    Qiu X; Chen J
    Curr Med Chem; 2023; 30(39):4409-4420. PubMed ID: 36734894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Stress Induced Non-Coding Transcripts 5 (LSINCT5) Promotes Hepatocellular Carcinoma Progression Through Interaction with High-Mobility Group AT-hook 2 and MiR-4516.
    Li O; Li Z; Tang Q; Li Y; Yuan S; Shen Y; Zhang Z; Li N; Chu K; Lei G
    Med Sci Monit; 2018 Nov; 24():8510-8523. PubMed ID: 30472720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long stress-induced non-coding transcript 5: A promising therapeutic target for cancer treatment.
    Yang W; Yang X; Li Q; Cao P; Tang L; Xie Z; Lei X
    Adv Clin Exp Med; 2023 Jan; 32(1):97-106. PubMed ID: 36083254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LSINCT5 drives proliferation and migration of oral squamous cell carcinoma through the miRNA-185-5p/ZNF703 axis.
    Wang X; Feng X; Wang H
    J BUON; 2021; 26(1):124-131. PubMed ID: 33721442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long non-coding RNA LSINCT5 promotes malignancy in non-small cell lung cancer by stabilizing HMGA2.
    Tian Y; Zhang N; Chen S; Ma Y; Liu Y
    Cell Cycle; 2018; 17(10):1188-1198. PubMed ID: 29883241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSINCT5 activates Wnt/β-catenin signaling by interacting with NCYM to promote bladder cancer progression.
    Zhu X; Li Y; Zhao S; Zhao S
    Biochem Biophys Res Commun; 2018 Jul; 502(3):299-306. PubMed ID: 29772237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer.
    Xu MD; Qi P; Weng WW; Shen XH; Ni SJ; Dong L; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
    Medicine (Baltimore); 2014 Dec; 93(28):e303. PubMed ID: 25526476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
    Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition.
    Qi P; Lin WR; Zhang M; Huang D; Ni SJ; Zhu XL; Bai QM; Sheng WQ; Du X; Zhou XY
    Cancer Manag Res; 2018; 10():2563-2571. PubMed ID: 30127643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LSINCT5 acts as an oncogene via increasing EZH2-induced inhibition of APC expression in osteosarcoma.
    Kong D; Li C; Yang Q; Wei B; Wang L; Peng C
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):193-197. PubMed ID: 30420287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451.
    Liu B; Cao W; Ma H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2507-2515. PubMed ID: 31213092
    [No Abstract]   [Full Text] [Related]  

  • 12. LncRNA LSINCT5/miR-222 regulates myocardial ischemia‑reperfusion injury through PI3K/AKT pathway.
    Tong X; Chen J; Liu W; Liang H; Zhu H
    J Thromb Thrombolysis; 2021 Oct; 52(3):720-729. PubMed ID: 34184201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNHG11: A New Budding Star in Tumors and Inflammatory Diseases.
    Wu Y
    Mini Rev Med Chem; 2023; 23(20):1993-2006. PubMed ID: 37165588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSINCT5 predicts unfavorable prognosis and exerts oncogenic function in osteosarcoma.
    He W; Lu M; Xiao D
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of knockout of long-chain non-coding RNA LSINCT5 on proliferation, apoptosis, epithelial-mesenchymal transition, and p38MAPK pathway of pancreatic cancer PANC-1 cells.
    Dai Y; Wu L; Zhang Z; Ou Y; Huang J
    Transl Cancer Res; 2020 Mar; 9(3):1418-1426. PubMed ID: 35117489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA LSINCT5 Regulates miR-20a-5p/XIAP to Inhibit the Growth and Metastasis of Osteosarcoma Cells.
    Liao SA; Guan J; Mo H; He JL; Zhan XL
    Onco Targets Ther; 2020; 13():8209-8221. PubMed ID: 32884299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p.
    Liang H; Zhang C; Guan H; Liu J; Cui Y
    J Cell Physiol; 2019 May; 234(5):7266-7278. PubMed ID: 30362591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LSINCT5 inactivates Wnt/β-catenin pathway to regulate MCF-7 cell proliferation and motility through targeting the miR-30a.
    Zhang G; Song W
    Ann Transl Med; 2020 Dec; 8(24):1635. PubMed ID: 33490147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long non
    Chen Y; Liu J; Lu T; Tang J; Li L; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):886-891. PubMed ID: 33053528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.